Swiss Hemophilia Registry

October 25, 2022 updated by: Swiss Hemophilia Network
The Swiss Hemophilia Registry will collect data on the prophylactic and therapeutic use of factor concentrates in patients with hemophilia and other severe bleeding disorders in Switzerland.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Switzerland
      • Aarau, Switzerland, 5001
        • Recruiting
        • Kantonsspital Aarau Zentrum für Onkologie/Hämatologie und Transfusionsmedizin
        • Contact:
      • Aarau, Switzerland, 5001
        • Recruiting
        • Kinderklinik
      • Basel, Switzerland, 4031
        • Recruiting
        • Universitätsspital Basel Diagnostische Hämatologie
        • Contact:
      • Basel, Switzerland, 4056
        • Recruiting
        • Universitätskinderspital beider Basel (UKBB) Abteilung Onkologie/Hämatologie
        • Contact:
      • Bellinzona, Switzerland, 6500
        • Recruiting
        • Ospedale San Giovanni
        • Contact:
      • Bellinzona, Switzerland, 6500
        • Recruiting
        • Servizio di Ematologia Ospedale Regionale di Bellinzona e Valli
        • Contact:
      • Bern, Switzerland, 3010
        • Recruiting
        • Inselspital, Universitätsspital Bern Poliklinik für Hämatologie
        • Contact:
      • Chur, Switzerland, 7000
        • Recruiting
        • Kantonspital Graubunden
        • Contact:
      • Genève, Switzerland, 1211
      • Genève, Switzerland, 1211
        • Recruiting
        • Unité d'Oncologie-Hématologie pédiatrique, Hôpital des Enfants HUG
        • Contact:
      • Lausanne, Switzerland, 1011
        • Recruiting
        • Centre Hospitalier Universitaire Vaudois Service d'Hématologie
        • Contact:
      • Lausanne, Switzerland, 1011
        • Recruiting
        • Policlinique d'onco-hématologie péd., CHUV
        • Contact:
      • Luzern, Switzerland, 6000
        • Recruiting
        • Kantonsspital Luzern Abteilung Hämatologie
        • Contact:
      • Luzern, Switzerland, 6000
      • Sion, Switzerland, 1950
        • Not yet recruiting
        • Kinder und Erwachsenenzentrum Sion Service Régional Valaisan de Transfusion Sanguine CRS
        • Contact:
      • St. Gallen, Switzerland, 9006
        • Recruiting
        • Ostschweizer Kinderspital St. Gallen
        • Contact:
      • St. Gallen, Switzerland, 9007
      • Zürich, Switzerland, 8032
      • Zürich, Switzerland, 8090
        • Recruiting
        • University Hospital Zürich
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with hemophilia and other severe bleeding disorders

Description

Inclusion Criteria:

Diagnosis of hemophilia or other severe bleeding disorders. Signed inform consent

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of incidence of disease and inhibitor development
Time Frame: 1 year
Demographics, Comorbidties, factor consumption for prophylaxis, bleeding and surgery, inhibito develeopment
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Swiss Hemophilia Network

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Anticipated)

December 1, 2025

Study Completion (Anticipated)

December 1, 2025

Study Registration Dates

First Submitted

July 26, 2015

First Submitted That Met QC Criteria

July 29, 2015

First Posted (Estimate)

July 30, 2015

Study Record Updates

Last Update Posted (Actual)

October 27, 2022

Last Update Submitted That Met QC Criteria

October 25, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2014-0667

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemophilia and Other Severe Bleeding Disorders

Clinical Trials on Registry

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe